Oppenheimer & Co. Inc., a New York-based brokerage firm with CRD number 249, recently settled a FINRA enforcement action over customer account statements that misidentified private-label collateralized mortgage obligations. The settlement resulted in a $250,000 fine and a firm censure.
The case, issued on May 4, 2026, is a clear example of how inaccurate account labels can mislead investors about the nature and risk of their holdings. It also shows that firms must have supervisory systems strong enough to catch categorization errors before they reach thousands of customer statements.
The FINRA settlement
Table of Contents
FINRA case number 2023077058901 involved a letter of acceptance, waiver, and consent, commonly called an AWC. Oppenheimer agreed to the sanctions without admitting or denying the findings. In addition to the fine and censure, the firm agreed to comply with the undertakings outlined in the AWC.
According to the settlement, Oppenheimer generated and sent approximately 167,000 account statements to more than 800 customers. Those statements listed private-label CMOs under the heading “Government Agency Bonds.” That heading was inaccurate and misleading because private-label CMOs are not guaranteed by the United States government or a government-sponsored enterprise.
After FINRA raised the issue, Oppenheimer changed the label to “Corporate Bonds.” That label was also wrong. Private-label CMOs differ from corporate bonds in several respects, including their structure, risk profile, and source of backing. Neither label correctly described the actual investment held by the customer.
What FINRA found about Oppenheimer’s supervision
FINRA found that Oppenheimer failed to establish and maintain a supervisory system, including written supervisory procedures, reasonably designed to verify the accuracy of customer account statements. The firm’s written procedures required a bi-monthly review of a sample of statements, but the review focused mainly on numerical accuracy.
The review did not include any step to determine whether customer holdings were accurately categorized. Because of that gap, Oppenheimer did not detect that private-label CMOs were being mislabeled as government agency bonds and then corporate bonds across a large volume of account statements.
The case highlights the difference between checking numbers and checking meaning. A statement can show the correct number of shares or principal amount while still giving a customer the wrong impression about what kind of investment is held. A supervisory system that only verifies arithmetic is not enough to protect investors from misleading descriptions.
What are private-label CMOs?
A private-label collateralized mortgage obligation is a type of mortgage-backed security issued by a private entity rather than a government agency or government-sponsored enterprise. It is backed by pools of residential mortgage loans, but it does not carry the full faith and credit guarantee of the United States government.
Government agency bonds and government-sponsored enterprise securities carry explicit or implied backing that private-label CMOs do not. Corporate bonds, by contrast, represent debt issued by companies and are evaluated based on the issuer’s creditworthiness. Private-label CMOs do not fit into either category because their performance depends on mortgage cash flows, prepayment risk, and credit risk within the underlying loan pool.
When a private-label CMO is labeled as a government agency bond, an investor may believe the position is safer or backed differently than it actually is. That misunderstanding can affect decisions about whether to hold, sell, or purchase more of the security. A label that suggests corporate-bond characteristics can be equally misleading because it ignores the prepayment and default risks tied to the mortgage collateral.
The broader regulatory context
Brokerage firms are required to provide accurate account statements under SEC and FINRA rules. Those statements must describe customer holdings in a way that is not false or misleading. Account labels are not just formatting; they communicate the nature of the investment and the source of any backing or guarantee.
FINRA has repeatedly emphasized that firms must have supervisory systems reasonably designed to ensure the accuracy of customer communications, including statements. In the Oppenheimer matter, the supervisory review was too narrow to satisfy that obligation.
What this means for Oppenheimer customers
Investors who held private-label CMOs at Oppenheimer should review their account statements from the relevant period. Look for holdings described as “Government Agency Bonds” or “Corporate Bonds” that were actually private-label CMOs.
If the mislabeling led to a misunderstanding of the investment’s risk, and if that misunderstanding caused financial harm, the investor may have a claim. The first step is to gather account statements, trade confirmations, and any notes about why the investment was held or sold. A lawyer can then compare the statement labels to the actual securities and evaluate whether the mislabeling affected investment decisions.
Even investors who did not lose money directly may have a claim if the mislabeling caused them to hold a riskier position than intended. The impact depends on the specific facts of each account.
How Investment Fraud Lawyers can help
Haselkorn & Thibaut, P.A., operating as Investment Fraud Lawyers, represents investors harmed by inaccurate statements, unsuitable recommendations, and failures in firm supervision. Our attorneys review account records, identify miscategorized holdings, and pursue claims through FINRA arbitration when appropriate.
If you held private-label CMOs or other fixed-income investments at Oppenheimer & Co. Inc. and believe you were misled by inaccurate account statements, contact us for a free case review. Securities claims have time limits, so acting promptly is important.
Call 1-888-885-7162 or reach out online. We work on a contingency basis, and past results do not guarantee future outcomes.
Frequently asked questions
What is FINRA case 2023077058901?
It is the enforcement action in which Oppenheimer & Co. Inc. agreed to a $250,000 fine and censure for mislabeling private-label CMOs on customer account statements.
What is a private-label CMO?
A private-label collateralized mortgage obligation is a mortgage-backed security issued by a private entity. It is backed by mortgage loans and is not guaranteed by the United States government.
Why was the “Government Agency Bonds” label misleading?
The label suggested that the CMOs were backed by the government or a government-sponsored entity, which was not true.
What did Oppenheimer’s supervisory review miss?
The bi-monthly review focused on numerical accuracy and did not check whether holdings were correctly categorized.
How many account statements were involved?
FINRA estimated that Oppenheimer sent approximately 167,000 mislabeled statements to more than 800 customers.
Can investors recover losses caused by mislabeled statements?
Possibly. If a misleading statement caused an investor to make a decision that resulted in losses, there may be a claim against the firm.
How do I start a claim review?
Call 1-888-885-7162 or contact Investment Fraud Lawyers online. We will review your statements and explain your options at no upfront cost.
Disclaimer: Past results do not guarantee future outcomes. This page provides general information and is not legal advice. No attorney-client relationship is formed by reading this content.
There is no guaranteed recovery in any securities matter. Consult a qualified attorney regarding your specific situation.
